Contact
About Nucletron
About Nucletron
Company History
Nucletron Worldwide
Careers
Management Board
Resource Library
About Brachytherapy
Patient information
Products & Solutions
Type of cancer
Head & Neck
Skin & Surface
Bronchus & Esophagus
Prostate
Rectum & Bladder
Breast
Pancreas & Bile Duct
Gynecology
Type of product
Imaging
Treatment Planning
Treatment Delivery
Applicators
Service & Support
Service and Support
oncoSupport Discover
What's new and what's next in radiation oncology
oncoSupport Define
Complete planning and project management
oncoSupport Deliver
Maintain and enhance your radiation oncology solutions
oncoSupport Develop
New services and new solutions
Training & Education
Training and Education
An overview of all training and education opportunities at Nucletron
Choose Category
Application Courses
Technical Courses
Clinical Workshop
My Nucletron
Login
Login to My Nucletron
Register
Register a new account
Forgot password?
Request a new password
Home
News & Events
NUCLETRON’S ONCENTRA® BRACHY TREATMENT PLANNING SOLUTION RECEIVES UNITED STATES REGULATORY CLEARANCE
June 2 2008
COLUMBIA, MD (June 2, 2008)—Nucletron, a knowledge-based leader in radiation oncology, today announced U.S. Food and Drug Administration clearance of Oncentra® Brachy, the company’s new comprehensive volume-based treatment planning solution to optimize cancer treatment planning with brachytherapy.
“We are pleased to receive clearance by the FDA for Oncentra Brachy,” said Jeroen Cammeraat, chief operating officer of Nucletron. “With this new treatment planning solution, Nucletron has set a benchmark in technological achievement, and has opened the door to new treatment techniques in brachytherapy planning not available before.
”Oncentra Brachy, the world’s first fully DICOM-compatible treatment planning system, features state-of-the-art optimization algorithms to shorten time spent planning. Among the many outstanding features the new solution provides are exceptional 3D contouring and margining tools to identify Regions of Interests (ROIs) on CT or in multimodality imaging environments using image registration for CT, MR and PET data.
“Radiation therapy professionals will have an opportunity to experience Oncentra Brachy hands-on as a component of Nucletron’s multi-modality suite of treatment planning solutions at the 2008 AAPM Annual Meeting in Houston in July,” said Bill Dowd, vice president of North America. “We invite attendees interested in learning more about Oncentra Brachy to stop by Nucletron’s booth (#600), and also consider participating in our ‘Lunch and Learn’ educational sessions as well as one of our celebration events.”
About Nucletron
Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams – reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit
http://www.nucletron.com/
.